FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approves a supplemental application for Norditropin (somatropin) from Novo Nordisk, indicating changes to labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Idiopathic Short Stature
• Noonan Syndrome
• Prader-willi Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• Norditropin (somatropin)

Snippet

SUPPL AP for NORDITROPIN (SOMATROPIN)